Heart Test Laboratories (NASDAQ:HSCS) stock is falling hard on Wednesday after the medical technology company announced a secondary offering for its shares.
Heart Test Laboratories notes that this is a resale of 34,684,859 shares of HSCS stock by a few shareholders.
Let’s break down the shares that are being sold and their holders below!
HSCS Stock Sale Details
- Icahn School of Medicine at Mount Sinai is selling 4,854,853 shares issued on November 16, 2023.
- This also includes 710,605 shares from pre-funded warrants issued at that same time.
- Another 914,148 shares are included in this from warrants included in that purchase agreement.
- 21,423,965 of these shares were issued to Lincoln Park Capital Fund, LLC in a March 10, 2023 purchase agreement.
- 3,656,288 shares are those issued to John Q. Adams in a note conversion agreement from Nov. 16, 2023.
- 3,125,000 shares come from a note conversion letter agreement with Matthews Southwest Holdings, Inc. on Nov. 16, 2023.
Heart Test Laboratories notes that it won’t see any funds from part of these sales. Instead, it will only see money from warrant exercises and the shares sold by Lincoln Park.
HSCS stock is down 20.7% as of Wednesday morning.
Investors can find even more of the most recent stock market stories worth reading about down below!
We have all of the hottest stock market stories that investors will want to keep up with on Wednesday! That includes why Entravision Communications (NYSE:EVC) stock is down, our trade of the day, and the latest news moving Infobird (NASDAQ:IFBD) stock. You can read up on all of these matters at the following links!
More Stock Market News for Wednesday
On the date of publication, William White did not have (either directly or indirectly) any positions in the securities mentioned in this article. The opinions expressed in this article are those of the writer, subject to the InvestorPlace.com Publishing Guidelines.
With only the rarest exceptions, InvestorPlace does not publish commentary about companies that have a market cap of less than $100 million or trade less than 100,000 shares each day. That’s because these “penny stocks” are frequently the playground for scam artists and market manipulators. If we ever do publish commentary on a low-volume stock that may be affected by our commentary, we demand that InvestorPlace.com’s writers disclose this fact and warn readers of the risks.
Read More: Penny Stocks — How to Profit Without Getting Scammed
